DNASTAR, Scarab Genomics announce launch of DNA and RNA sequencing services business

DNASTAR® and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.

“Nobody knows our sequence assembly and analysis software better than we do. Using software we commercialize in addition to some tools we've developed specifically to support our services business, we have the ability to deliver results very effectively and efficiently.”

Tom Schwei, Vice President and General Manager of DNASTAR, stated, "Nobody knows our sequence assembly and analysis software better than we do. Using software we commercialize in addition to some tools we've developed specifically to support our services business, we have the ability to deliver results very effectively and efficiently."

Schwei also said, "In recent years, we've specifically added to DNASTAR and Scarab Genomics a group of life scientists with expertise in DNA and RNA sequence assembly and finishing to support the launch of this aspect of our business. It is natural for DNASTAR and Scarab to join together to provide these services for others who prefer to tap into our expertise."

Tony Pharo, Director of Business Development and Operations for Scarab Genomics, added, "While DNASTAR brings strong informatics capabilities, Scarab's wet-lab expertise adds a necessary complementary part of the comprehensive offering. We are pleased to find a way to work together in this new venture."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study identifies common misuses of spike-in normalization